XML 88 R85.htm IDEA: XBRL DOCUMENT v2.4.0.6
DISTRIBUTION AGREEMENTS AND MAJOR CUSTOMERS (Detail Textuals 1) (USD $)
In Millions, unless otherwise specified
12 Months Ended 12 Months Ended
Dec. 31, 2012
Surgical products
Dec. 31, 2012
C R Bard
Dec. 31, 2011
C R Bard
Dec. 31, 2010
C R Bard
Dec. 31, 2012
C R Bard
Brachytherapy Seed
Dec. 31, 2011
C R Bard
Brachytherapy Seed
Dec. 31, 2010
C R Bard
Brachytherapy Seed
Dec. 31, 2011
Core Oncology
Dec. 31, 2010
Core Oncology
Dec. 31, 2011
Core Oncology
Brachytherapy Seed
Dec. 31, 2010
Core Oncology
Brachytherapy Seed
Feb. 17, 2012
Core Oncology
Brachytherapy Seed
Revenue, Major Customer [Line Items]                        
Percentage of accounts receivable 17.00%       16.00% 19.00%            
Percentage of consolidated accounts receivable 11.00% 10.00% 10.00%                  
Percentage of revenue         25.00% 28.00% 33.00%     8.00% 14.00%  
Percentage of consolidated revenue   10.00% 10.00% 11.00%                
Allowance for doubtful accounts receivable               $ 2.2 $ 2.1 $ 1.8 $ 1.7  
Allowances for accounts receivable, written off                       $ 2.2